Member Info for Saintsmith

Some great feedback from our guys in the telegram group who attended both meetings .

Getting a further working agreement with the NCI is huge . You could not get a more prestigious sign of approval of how well optimal works .

Patent granted and NCI approval , launch in December .

Lots of news been released by the company .

Great things happening.

FAB has been over £1 before and we have so much more to offer that has been industry validated now and patented .

I predict over £1 at some point next year if we are not bought out for more .

Fantastic news . This is BIG . All the ducks are starting to line up very nicely.

Having previously and currently working with 8 out of 10 of the biggest global pharmaceutical companies i wonder how many of the will want exclusivity to what FAB has to offer ????

Bidding war incoming after this very busy news period ???

Very exciting times over the next few months .

Yep , I am feeling really positive about this share . Just look at its competitors market caps . I was in Novacyt from early days and watched the SP rocket . I firmly believe the same will happen here , that is why I have loaded up big style . Still continuing to do so Also . Strap in guys and girls .

Wow , a rise , has Lynn rhyss handed his notice in ?

Do not forget optimals launch in December .

Many key players from big pharma attending .

Great news , we have the patent , the optimal library works and I would not be at all surprised if NCI validation is also round the corner.

This tech is groundbreaking , revolutionary and a worlds first .

This will be shouted from the rooftops in San Diego and will be well on the radar of the big boys .

R&D update: Mammalian Display service - Fusion Antibodies

Fusion Antibodies is planning a commercial launch of its OptiMAL® antibody library platform at the Antibody Engineering and Therapeutics conference in San Diego in December 2025. This launch follows the recent grant of a U.S. patent for the OptiMAL® technology. The platform is designed for antibody discovery, affinity maturation, and sequence optimization.

guys this is a busted flush . instead of moping around here start looking for other opportunities. lynn rhyss will destroy this company just like he did with yourgene .

sorry for the cross ramp but #fab well worth a look at the moment .

novacyt couldn’t sell beer to a ****head.

Great news , thanks to a lot of detective work from gtc and others we knew this patent was granted and now it has been announced bang in time .

So our main focus for sales is the US , hence why we aimed for the US patent first. Hopefully once commercially launched , if not before we should start see income generation .

Next patents will be received from Europe, China and Japan .

“Optimal “ soon to be worldwide bringing in a lot of orders and new deals .

Let us just say that three big competing pharmaceutical companies are all paying to use “ optimal “ . Any commercial and timesaving advantages will be shared with others . Unless exclusivity deals are announced to each company . So this is why in my opinion once we have ( which we know have been passed and just need to be announced to market) and NCI approval granted this will in my opinion be bought by one of these big pharma to grant total exclusivity and ownership of the “optimal “ library . That is not to mention all other things they have going on .

Definition of a “step change “ in business. Let’s hope our CEO means it , he is not normally this bullish .

“In business, a step change refers to a significant, often sudden and transformative, improvement or alteration in a company's operations, structure, or performance. It's a radical shift away from the current state, aiming for a substantial leap forward rather than incremental adjustments. This can involve changes to business models, technology, markets, or even the company's culture “

Once this is validated we could very much be invested in a market disrupting company . Many big pharmas will be watching and will want this technology . A potential game changer . This could be huge .

“Market-disrupting companies are businesses that introduce innovations that significantly alter the competitive landscape of an industry, often leading to the displacement of established players or the creation of entirely new markets. These companies challenge the status quo by offering new products, services, or business models that are more efficient, convenient, or affordable than existing options. “

Hold tight , now that is my advice 😉

We have been working very closely with Dr Mitchell Ho along with the NCI .

He is an expert in his field . Google him. . Patent first , then NCI then who knows what else 😉

Optimal could very well be game changing once it is validated .

Patents on the way.

I expect big pharma is watching very closely.

The reverse take over of Novacyt to yourgene continues . That is until LR burns through the rest of what is left of the Covid windfall .

Yep thanks muck and hello harchris . I feel that things are looking rosy for abdx this year . Slightly disappointed that the SP is not higher especially after the salistick pregnancy test . I really thought that could be groundbreaking . It may yet come good still .

Still investing here and I’m also in fusion anti bodies also well worth researching and hoping for nice gains there too in 2025. Apologies for cross ramp .

That tells me all I need to know to not invest anymore in this company

“SUBJECT TO THE APPROVAL OF THE RESOLUTIONS AT THE GENERAL MEETING, IF THE MINIMUM FUNDRAISING CONDITION IS NOT SATISFIED, WHILE THE SUBSCRIPTION WOULD STILL PROCEED, THE COMPANY INTENDS TO APPLY FOR THE CANCELLATION OF ITS ORDINARY SHARES FROM TRADING ON AIM IN EARLY 2025”

It’s quite simple Novacyt can not sell their products , their reputation is tarnished from the DHSC debarcle.

They may be debt free at the moment but with Lynn Rhyss in charge he will spunk what’s left in the kitty within the next two years and run Novacyt into the ground just like he did at yourgene .

It’s very much under the radar this share .

. Personally waiting for more info with the NCI .

Then it will start getting more investors attention .

Good to see directors buys , hopefullly news is on the horizon ??

Do not fall for the fear mongering regarding even newer , deadlier diseases .

Roll up your sleeves for the jabs guys 😉